Wenhui Zhang

Safety, Pharmacokinetic, and Pharmacodynamic Profiles of Ipragliflozin (ASP1941), a Novel and Selective Inhibitor of Sodium-Dependent Glucose Co-Transporter 2, in Patients with Type 2 Diabetes Mellitus

Sherwyn Schwartz, Bola Akinlade, Sally Klasen et al. · Diabetes Technology & Therapeutics · 2011 · 68 citations

Medicine, Pharmacokinetics, Pharmacology +17

Long-Term Use of Metformin Is Associated With Reduced Risk of Cognitive Impairment With Alleviation of Cerebral Small Vessel Disease Burden in Patients With Type 2 Diabetes

Zhenjie Teng, Jing Feng, Qianqian Qi et al. · Frontiers in Aging Neuroscience · 2021 · 40 citations · Full text

Medicine, Neurology, Neuroscience +17

Specialized Retinal Endothelial Cells Modulate Blood-Retina Barrier in Diabetic Retinopathy

Xuyang Yao, Ziyan Zhao, Wenhui Zhang et al. · Diabetes · 2023 · 28 citations

Medicine, Cell Biology, Ophthalmology +16

The Effect of Moderate Hepatic Impairment on the Pharmacokinetics of Ipragliflozin, a Novel Sodium Glucose Co-Transporter 2 (SGLT2) Inhibitor

Wenhui Zhang, Walter Krauwinkel, James J. Keirns et al. · Clinical Drug Investigation · 2013 · 26 citations

Pharmacy, Pharmacokinetics, Pharmacology +14

Astegolimab or Efmarodocokin Alfa in Patients With Severe COVID-19 Pneumonia: A Randomized, Phase 2 Trial*

Michael R. Waters, James A. McKinnell, André C. Kalil et al. · Critical Care Medicine · 2022 · 23 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +17